Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7318 p407
25 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacy redeveloped for enhanced services

Graham Phillips (left) with Oliver Heald

Graham Phillips (left) with Oliver Heald

A Hertfordshire pharmacy has been redeveloped so that it can offer enhanced services under the new pharmacy contract. In particular, the local primary care trust wants the pharmacy to provide dermatology and phlebotomy services.

The newly refurbished Manor Pharmacy in Letchworth was opened on 17 September by local MP Oliver Heald. Pharmacy owner Graham Phillips explained: “I have a long-standing interest in public health so I approached the PCT to find out what its priorities are in this area. I also wanted to integrate public health with prescribing.”

Mr Phillips, who is a member of the Royal Pharmaceutical Society’s Council, then produced a proposal for development of his pharmacy with the chief pharmacist and the assistant director of public health at North Herts and Stevenage PCT. It identified targets in a number of national and local documents, and described how the pharmacy could help to meet these targets.

New facilities at the pharmacy include a dedicated patient counselling area, a private consultation room, networked HealthPoint computers and a WellPoint station. Among the services the pharmacy is now offering are diabetes monitoring, blood pressure monitoring, cholesterol monitoring, osteoporosis testing and asthma management.

The pharmacy will begin to provide further new services within the next few weeks. First, a dermatology service was requested by the PCT because of a lack of consultant dermatologists in the locality and because dermatology telemedicine offered by a specialist nurse has proved expensive. “We found we could cut 50 per cent of this workload,” explained Mr Phillips. Roles will include providing advice on appropriate use of moisturisers, avoiding lifestyle irritants and over-use of corticosteroids.

The phlebotomy service is expected to extend beyond taking blood samples to interpreting results and making recommendations under a protocol from GPs.

Back to Top


©The Pharmaceutical Journal